199 related articles for article (PubMed ID: 23204222)
1. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.
Diamandis EP; Bast RC; Gold P; Chu TM; Magnani JL
Clin Chem; 2013 Jan; 59(1):22-31. PubMed ID: 23204222
[No Abstract] [Full Text] [Related]
2. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based delta check method for detecting misidentification errors in tumor marker tests.
Seok HS; Choi Y; Yu S; Shin KH; Kim S; Shin H
Clin Chem Lab Med; 2024 Jun; 62(7):1421-1432. PubMed ID: 38095534
[TBL] [Abstract][Full Text] [Related]
4. Tumor marker workshops.
Rye PD; Nustad K; Stigbrand T
Tumour Biol; 2003; 24(4):165-71. PubMed ID: 14654709
[TBL] [Abstract][Full Text] [Related]
5. Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.
Nummela P; Leinonen H; Järvinen P; Thiel A; Järvinen H; Lepistö A; Ristimäki A
Hum Pathol; 2016 Aug; 54():47-54. PubMed ID: 27038681
[TBL] [Abstract][Full Text] [Related]
6. Trypsin enhances aptamer screening: A novel method for targeting proteins.
Gu L; Yan W; Liu S; Ren W; Lyu M; Wang S
Anal Biochem; 2018 Nov; 561-562():89-95. PubMed ID: 30196049
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
8. Ultrasound imaging of pseudomyxoma peritonei with numerous vesicles in ascitic fluid.
Matsumi H; Kozuma S; Osuga Y; Yano T; Yoshikawa H; Tsutsumi O; Taketani Y
Ultrasound Obstet Gynecol; 1999 May; 13(5):378-9. PubMed ID: 10380313
[No Abstract] [Full Text] [Related]
9. [Molecular microheterogeneity of tumor marker substances and its significance of biological recognition].
Kuwabara M; Iwakoshi N; Ariyoshi Y
Nihon Rinsho; 1996 Jun; 54(6):1580-6. PubMed ID: 8691612
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
11. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities, failures and prospects of studies on tumor markers in oncological clinics. 1. (lecture)].
Kushlinskiĭ NE
Klin Lab Diagn; 1999 Mar; (3):25-32. PubMed ID: 10234929
[No Abstract] [Full Text] [Related]
14. [A case of primary mucinous adenocarcinoma of jejunum].
Maeda T; Iwasaki M; Hamaya M; Kameya S
Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):972-5. PubMed ID: 9488985
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers in hemodialysis patients.
Maoujoud O; El Machtani S; Asseraji M; Atbib Y; Zajjari Y; Taoufik A; Elbouaiti E; Zouhair O; Benyahia M; Tellal S
Int J Artif Organs; 2014 Feb; 37(2):126-32. PubMed ID: 24619900
[TBL] [Abstract][Full Text] [Related]
16. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
[TBL] [Abstract][Full Text] [Related]
17. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
18. Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
Christenson RH; Cervelli DR; Sterner J; Bachmann LM; Rebuck H; Gray J; Kelley WE
Clin Biochem; 2011 Sep; 44(13):1128-1136. PubMed ID: 21704611
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
[TBL] [Abstract][Full Text] [Related]
20. Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix.
Borras G; Molina R; Xercavins J; Ballesta A; Iglesias J
Gynecol Oncol; 1995 May; 57(2):205-11. PubMed ID: 7729735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
